ProKidney provides final Phase 2 RMCL-002 data; specifics not in filing text

PROKIDNEY CORP.

Company furnished investor presentation with final data from Phase 2 RMCL-002 clinical trial.
Presentation available on ProKidney's website; full data not included in 8-K excerpt.
Trial targets dialysis prevention; efficacy/safety figures not disclosed in filing.
No financial or operational updates beyond the trial data release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.